The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
The systemic inflammatory response syndrome in acute liver failure
Open accessAbstract
The systemic inflammatory response syndrome (SIRS) in acute liver failure (ALF), in which infection is common, has not been studied. In this study, SIRS components were recorded on admission and during episodes of infection, in 887 ALF patients admitted to a single center during an 11-year period. Overall, 504 (56.8%) patients manifested a SIRS during their illness, with a maximum of 1, 2, and 3 concurrent SIRS components in 166, 238, and 100 patients, respectively. In 353 (39.8%) patients who did not become infected, a SIRS on admission was associated with a more critical illness, subsequent worsening of encephalopathy, and death. Infected patients more often developed a SIRS and one of greater magnitude. The magnitude of the SIRS in 273 patients with bacterial infection correlated with mortality, being 16.7%, 28.4%, 41.2%, and 64.7% in patients with 0, 1, 2, and 3 maximum concurrent SIRS components, respectively. Similar correlations with mortality were seen for SIRS associated with fungal infection, bacteremia, and bacterial chest infection. Fifty-nine percent of patients with severe sepsis died, as did 98% of those with septic shock. A significant association was found between progressive encephalopathy and infection. Infected patients with progressive encephalopathy manifested more SIRS components than other infected patients. For patients with a SIRS, the proportions of infected and noninfected patients manifesting worsening encephalopathy were similar. In ALF, the SIRS, whether or not precipitated by infection, appears to be implicated in the progression of encephalopathy, reducing the chances of transplantation and conferring a poorer prognosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study
Rangel-Frausto, M. S. (1995) · JAMA · doi:10.1001/jama.273.2.117 · Cited by 2,104
Bone, R. C. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-6-457 · Cited by 1,368
Waage, A., Halstensen, A., & Espevik, T. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91728-4 · Cited by 1,096
The Role of Interleukin-1 in Disease
Epstein, F. H., Dinarello, C. A., & Wolff, S. M. (1993) · New England Journal of Medicine · doi:10.1056/nejm199301143280207 · Cited by 954
Kwiatkowski, D., Sambou, I., Twumasi, P., Greenwood, B. M., Hill, A. V. S., Manogue, K. R., Cerami, A., Castracane, J., & Brewster, D. R. (1990) · The Lancet · doi:10.1016/0140-6736(90)92827-5 · Cited by 872
Glauser, M. P., Zanetti, G., Baumgartner, J.-D., & Cohen, J. (1991) · The Lancet · doi:10.1016/0140-6736(91)91452-z · Cited by 716
Lee, W. M. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312163292508 · Cited by 546
Cytokine appearance in human endotoxemia and primate bacteremia.
HESSE, D. G., Tracey, K. J., Fong, Y., Manogue, K. R., Palladino, M. A., Cerami, A., Shires, G. T., & Lowry, S. F. (1988) · PubMed · Cited by 532
POLIOMYELITIS AND TONSILLECTOMY
(1955) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1955.tb45053.x · Cited by 420
Cited by
Sarin, S. K., Kedarisetty, C. K., Abbas, Z., Amarapurkar, D., Bihari, C., Chan, A. C. Y., Chawla, Y. K., Dokmeci, A. K., Garg, H., Ghazinyan, H., et al. (2014) · Hepatology International · doi:10.1007/s12072-014-9580-2 · Cited by 1,481
“pointed out that elevated systemic levels are not representative of their role in the pathophysiology of liver failure [52– 54].”
Bernal, W., Auzinger, G., Dhawan, A., & Wendon, J. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60274-7 · Cited by 996
Self-citationAASLD position paper: The management of acute liver failure†
Polson, J., & Lee, W. M. (2005) · Hepatology · doi:10.1002/hep.20703 · Cited by 974
EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure
Wendon, J., Cordoba, J., Dhawan, A., Larsen, F. S., Manns, M., Nevens, F., Samuel, D., Simpson, K. J., Yaron, I., & Bernardi, M. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.12.003 · Cited by 917
Self-citationKeel, M., & Trentz, O. (2005) · Injury · doi:10.1016/j.injury.2004.12.037 · Cited by 885
Stravitz, R. T., & Lee, W. M. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31894-x · Cited by 844
Sarin, S. K., Kumar, A., Almeida, J. A., Chawla, Y. K., Fan, S. T., Garg, H., de Silva, H. J., Hamid, S. S., Jalan, R., Komolmit, P., et al. (2009) · Hepatology International · doi:10.1007/s12072-008-9106-x · Cited by 763
Larsen, F. S., Schmidt, L. E., Bernsmeier, C., Rasmussen, A., Isoniemi, H., Patel, V. C., Triantafyllou, E., Bernal, W., Auzinger, G., Shawcross, D., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.08.018 · Cited by 659
Self-citationAcute-on chronic liver failure
Jalan, R., Gines, P., Olson, J. C., Mookerjee, R. P., Moreau, R., Garcia-Tsao, G., Arroyo, V., & Kamath, P. S. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.06.026 · Cited by 646
Shawcross, D. L., Davies, N. A., Williams, R., & Jalan, R. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2003.10.016 · Cited by 539
Self-citationPatients with acute on chronic liver failure display ‘sepsis-like’ immune paralysis
Wasmuth, H. E., Kunz, D., Yagmur, E., Timmer-Stranghöner, A., Vidacek, D., Siewert, E., Bach, J., Geier, A., Purucker, E. A., Gressner, A. M., et al. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2004.10.019 · Cited by 539
Bernal, W., Hall, C., Karvellas, C. J., Auzinger, G., Sizer, E., & Wendon, J. (2007) · Hepatology · doi:10.1002/hep.21838 · Cited by 480
Self-citationArroyo, V., Angeli, P., Moreau, R., Jalan, R., Clària, J., Trebicka, J., Fernández, J., Gustot, T., Caraceni, P., & Bernardi, M. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2020.11.048 · Cited by 458
Lessons from look-back in acute liver failure? A single centre experience of 3300 patients
Bernal, W., Hyyrylainen, A., Gera, A., Audimoolam, V. K., McPhail, M. J. W., Auzinger, G., Rela, M., Heaton, N., O’Grady, J. G., Wendon, J., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.02.010 · Cited by 433
Self-citationStravitz, R. T., Kramer, A. H., Davern, T., Shaikh, A. O. S., Caldwell, S. H., Mehta, R. L., Blei, A. T., Fontana, R. J., McGuire, B. M., Rossaro, L., et al. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000287592.94554.5f · Cited by 422
Infection and the progression of hepatic encephalopathy in acute liver failure
Vaquero, J., Polson, J., Chung, C., Helenowski, I., Schiodt, F. V., Reisch, J., Lee, W. M., & Blei, A. T. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)01051-5 · Cited by 392
Murphy, N., Auzinger, G., Bernel, W., & Wendon, J. (2004) · Hepatology · doi:10.1002/hep.20056 · Cited by 382
Self-citationThe importance of immune dysfunction in determining outcome in acute liver failure
Antoniades, C. G., Berry, P. A., Wendon, J. A., & Vergani, D. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.08.009 · Cited by 367
Self-citationPrinciples of antibacterial dosing in continuous renal replacement therapy
Choi, G., Gomersall, C. D., Tian, Q., Joynt, G. M., Freebairn, R., & Lipman, J. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181aab3d0 · Cited by 334
Yao, Y., Zhang, H., Wang, Z., Ding, J., Wang, S., Huang, B., Ke, S., & Gao, C. (2019) · Journal of Materials Chemistry B · doi:10.1039/c9tb00847k · Cited by 318
Pathogenesis of Hepatic Encephalopathy: Role of Ammonia and Systemic Inflammation
Aldridge, D. R., Tranah, E. J., & Shawcross, D. L. (2015) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2014.06.004 · Cited by 313
Horst, A. K., Neumann, K., Diehl, L., & Tiegs, G. (2016) · Cellular & Molecular Immunology · doi:10.1038/cmi.2015.112 · Cited by 295
Acute-on-Chronic Liver Failure: Pathophysiological Basis of Therapeutic Options
Jalan, R., & Williams, R. (2002) · Blood Purification · doi:10.1159/000047017 · Cited by 286
Self-citationThe Role of Monocytes and Macrophages in Acute and Acute-on-Chronic Liver Failure
Triantafyllou, E., Woollard, K. J., McPhail, M. J. W., Antoniades, C. G., & Possamai, L. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02948 · Cited by 285
Shawcross, D. L., Sharifi, Y., Canavan, J. B., Yeoman, A. D., Abeles, R. D., Taylor, N. J., Auzinger, G., Bernal, W., & Wendon, J. A. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.07.045 · Cited by 283
Self-citationAntoniades, C. G., Quaglia, A., Taams, L. S., Mitry, R. R., Hussain, M., Abeles, R., Possamai, L. A., Bruce, M., McPhail, M., Starling, C., et al. (2012) · Hepatology · doi:10.1002/hep.25657 · Cited by 281
Self-citationAcute liver failure: mechanisms of immune-mediated liver injury
Wu, Z., Han, M., Chen, T., Yan, W., & Ning, Q. (2010) · Liver International · doi:10.1111/j.1478-3231.2010.02262.x · Cited by 274
Moderate hypothermia in patients with acute liver failure and uncontrolled intracranial hypertension
Jalan, R., Olde Damink, S. W. M., Deutz, N. E. P., Hayes, P. C., & Lee, A. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.08.005 · Cited by 269
Stravitz, R. T., Lisman, T., Luketic, V. A., Sterling, R. K., Puri, P., Fuchs, M., Ibrahim, A., Lee, W. M., & Sanyal, A. J. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.04.020 · Cited by 268
Acute liver failure: A curable disease by 2024?
Bernal, W., Lee, W. M., Wendon, J., Larsen, F. S., & Williams, R. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.12.016 · Cited by 257
Self-citationAlternatively activated macrophages promote resolution of necrosis following acute liver injury
Starkey Lewis, P., Campana, L., Aleksieva, N., Cartwright, J. A., Mackinnon, A., O'Duibhir, E., Kendall, T., Vermeren, M., Thomson, A., Gadd, V., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.02.031 · Cited by 209
Possamai, L. A., Thursz, M. R., Wendon, J. A., & Antoniades, C. G. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.03.031 · Cited by 153
Self-citationCell therapy for advanced liver diseases: repair or rebuild
Dwyer, B. J., Macmillan, M. T., Brennan, P. N., & Forbes, S. J. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2020.09.014 · Cited by 141
Khamri, W., Abeles, R. D., Hou, T. Z., Anderson, A. E., El-Masry, A., Triantafyllou, E., Bernsmeier, C., Larsen, F. S., Singanayagam, A., Kudo, N., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.03.023 · Cited by 49
“cute liver failure (ALF) occurs after a severe hepatic Ainsult resulting in a rapidly progressive clinical syndrome characterized by jaundice, encephalopathy, coagulopathy, and multiple organ dysfunction.(1,2) Although the initiating event in ALF is acute hepatocellular death, mortality is attributable to a profound a…”
BackgroundSelf-citationMicrobiota and the nitrogen cycle: Implications in the development and progression of CVD and CKD
Briskey, D., Tucker, P. S., Johnson, D. W., & Coombes, J. S. (2016) · Nitric Oxide · doi:10.1016/j.niox.2016.05.002 · Cited by 47
Macrophages as a Cell-Based Therapy for Liver Disease
Starkey Lewis, P. J., Moroni, F., & Forbes, S. J. (2019) · Seminars in Liver Disease · doi:10.1055/s-0039-1688502 · Cited by 36
Biagioli, M., Marchianò, S., di Giorgio, C., Roselli, R., Bordoni, M., Bellini, R., Fiorillo, B., Sepe, V., Catalanotti, B., Cassiano, C., et al. (2023) · Hepatology · doi:10.1002/hep.32787 · Cited by 28
Mallet, M., Haq, M., Tripon, S., Bernard, M., Benosman, H., Thabut, D., & Rudler, M. (2017) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000862 · Cited by 17
Arkadopoulos, N., Vlahakos, D., Kostopanagiotou, G., Panagopoulos, D., Karvouni, E., Routsi, C., Kalimeris, K., Andreadou, I., Kouskouni, E., & Smyrniotis, V. (2008) · Liver Transplantation · doi:10.1002/lt.21505 · Cited by 13
Candela, M. E., Addison, M., Aird, R., Man, T.-Y., Cartwright, J. A., Ashmore-Harris, C., Kilpatrick, A. M., Starkey Lewis, P. J., Drape, A., Barnett, M., et al. (2025) · npj Regenerative Medicine · doi:10.1038/s41536-025-00393-3 · Cited by 11
Metadata
- Authors
- Rolando, N., Wade, J., Davalos, M., Wendon, J., Philpott-Howard, J., & Williams, R.
- Venue
- Hepatology
- Published
- 2000-10
- Volume
- 32
- Issue
- 4
- Pages
- 734-739
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2112610029
- Cited by
- 729
- References
- 37
- FWCI
- 8.52
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.